KOSPI · Healthcare · ₩6T
₩79,400+0.63%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Short Volume 20.5% · as of 26.09.11
Among 98 제약 peers
Quarterly Revenue Growth
“신약 기대가 앞서고 실적 확인이 뒤따를 분기예요.”
In the company's words · 2026 2분기 filing